Dominique Merrien

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

François-Xavier Lescure, Hitoshi Honda, Robert Fowler et al. · The Lancet Respiratory Medicine · 2021 · 248 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Long‐Term Outcomes Among Participants in the WEGENT Trial of Remission‐Maintenance Therapy for Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis

Xavier Puéchal, Christian Pagnoux, Élodie Perrodeau et al. · Arthritis & Rheumatology · 2015 · 136 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patients

Clotilde Allavena, Matthieu Hanf, David Rey et al. · PLoS ONE · 2018 · 98 citations · Full text

Education, Geriatric Medicine, Infectious Diseases +14

Fluoroquinolone Use and Fluoroquinolone Resistance: Is There an Association?

P. Richard, M.-H. Delangle, Dominique Merrien et al. · Clinical Infectious Diseases · 1994 · 97 citations

Life Sciences, Infectious Diseases, Microbiology +17

Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial

Achim J. Kaasch, Luis Eduardo López-Cortés, Jesús Rodríguez‐Baño et al. · The Lancet Infectious Diseases · 2024 · 81 citations

Pharmacy, Pharmacotherapy, Infection Prevention +13